Inventor
KLIMKO PETER G
US49 patents
⚠️ This page may combine multiple inventors who share the name “KLIMKO PETER G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALCON UNIVERSAL LTD
12 patentsUS6300328B1Oct 9, 2001
Selective inhibitors of adenosine monophosphate deaminase for the treatment of optic nerve and retinal damage
ALCON UNIVERSAL LTD30 citations92
US6552084B2Apr 22, 2003
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
ALCON UNIVERSAL LTD7 citations74
US6458853B2Oct 1, 2002
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
ALCON UNIVERSAL LTD6 citations74
US6353012B1Mar 5, 2002
15-Hydroxyeicosatetraenoic acid-related compounds and methods of use
ALCON UNIVERSAL LTD8 citations74
US6331566B1Dec 18, 2001
Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
ALCON UNIVERSAL LTD6 citations74
US6331644B1Dec 18, 2001
3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use
ALCON UNIVERSAL LTD6 citations74
US6458854B2Oct 1, 2002
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
ALCON UNIVERSAL LTD6 citations63
US6441035B2Aug 27, 2002
Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
ALCON UNIVERSAL LTD3 citations63
US6437160B1Aug 20, 2002
3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use
ALCON UNIVERSAL LTD3 citations63
US6436994B2Aug 20, 2002
Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
ALCON UNIVERSAL LTD3 citations63
US6353032B1Mar 5, 2002
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
ALCON UNIVERSAL LTD5 citations63
US6342525B1Jan 29, 2002
Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders
ALCON UNIVERSAL LTD5 citations61
ALCON INC
11 patentsUS6740674B2May 25, 2004
Use of proteasome inhibitors to treat dry eye disorders
ALCON INC31 citations93
US6645978B1Nov 11, 2003
Lipoxin A4 and its analogs for the treatment of dry eye
ALCON INC39 citations92
US6576663B2Jun 10, 2003
6-Keto prostaglandin F1α and analogs for treating dry eye
ALCON INC9 citations74
US7923471B2Apr 12, 2011
Method of treating dry eye disorders and uveitis
ALCON INC3 citations63
US7879905B2Feb 1, 2011
5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses
ALCON INC0 citations52
US7759333B2Jul 20, 2010
Superoxide dismutase mimics for the treatment of ocular disorders and diseases
ALCON INC0 citations52
US7754706B2Jul 13, 2010
Superoxide dismutase mimics for the treatment of ocular disorders and diseases
ALCON INC0 citations52
US7112588B2Sep 26, 2006
Use of proteasome inhibitors to treat dry eye disorders
ALCON INC0 citations52
US7060728B2Jun 13, 2006
11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
ALCON INC0 citations51
US6750250B1Jun 15, 2004
11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
ALCON INC1 citations51
US6803385B2Oct 12, 2004
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
ALCON INC0 citations42
ALCON LAB INC
10 patentsUS6025392AFeb 15, 2000
substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
ALCON LAB INC87 citations97
US5994397ANov 30, 1999
Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
ALCON LAB INC63 citations95
US6184250B1Feb 6, 2001
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
ALCON LAB INC71 citations93
US5807892ASep 15, 1998
Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
ALCON LAB INC27 citations92
US5665773ASep 9, 1997
Cloprostenol and fluprostenol analogues and their use to treat glaucoma and ocular hypertension
ALCON LAB INC31 citations92
US6353014B1Mar 5, 2002
15-ketal postaglandins for the treatment of glaucoma or ocular hypertension
ALCON LAB INC8 citations74
US6353000B1Mar 5, 2002
11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
ALCON LAB INC10 citations74
US6211226B1Apr 3, 2001
11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
ALCON LAB INC7 citations74
US6197812B1Mar 6, 2001
Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
ALCON LAB INC1 citations62
US6235779B1May 22, 2001
Use of cis-Δ4 analogs of prostaglandins as ocular hypotensives
ALCON LAB INC0 citations42
ALCON MFG LTD
7 patentsUS6417228B1Jul 9, 2002
13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
ALCON MFG LTD24 citations92
US6680339B2Jan 20, 2004
15-fluoro prostaglandins as ocular hypotensives
ALCON MFG LTD7 citations74
US6723748B2Apr 20, 2004
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
ALCON MFG LTD2 citations63
US6649653B1Nov 18, 2003
15-fluoro prostaglandins as ocular hypotensives
ALCON MFG LTD2 citations63
US6462080B1Oct 8, 2002
Prostaglandin E receptor agonists for treatment of dry eye
ALCON MFG LTD2 citations63
US6545045B1Apr 8, 2003
Prostaglandin E agonists for treatment of glaucoma
ALCON MFG LTD3 citations61
US6344581B1Feb 5, 2002
Method of prostaglandin synthesis
ALCON MFG LTD0 citations52
ALCON RES LTD
5 patentsUS7625927B2Dec 1, 2009
Method of treating glaucoma
ALCON RES LTD52 citations97
US7745461B1Jun 29, 2010
Method of treating dry eye disorders
ALCON RES LTD6 citations63
US7807363B2Oct 5, 2010
Superoxide dismutase-2 expression for glaucoma diagnosis
ALCON RES LTD5 citations62
US8034839B2Oct 11, 2011
Method of treating ocular allergy
ALCON RES LTD3 citations59
US7687539B1Mar 30, 2010
Method of treating ocular allergy
ALCON RES LTD1 citations48